Intravenous Paracetamol (Acetaminophen)
▴ Intravenous paracetamol (rINN)/intravenous acetaminophen (USAN) is an analgesic and antipyretic agent, recommended worldwide as a first-line agent for the treatment of pain and fever in adults and children.
▴ In double-blind clinical trials, single or multiple doses of intravenous paracetamol 1 g generally provided significantly better analgesic efficacy than placebo treatment (as determined by primary efficacy endpoints) in adult patients who had undergone dental, orthopaedic or gynaecological surgery.
▴ Furthermore, where evaluated, intravenous paracetamol 1 g generally showed similar analgesic efficacy to a bioequivalent dose of propacetamol, and a reduced need for opioid rescue medication.
▴ In paediatric surgical patients, recommended doses of intravenous paracetamol 15 mg/kg were not significantly different from propacetamol 30 mg/kg for the treatment of pain, and showed equivocal analgesic efficacy compared with intramuscular pethidine 1 mg/kg in several randomized, active comparator-controlled studies.
▴ In a randomized, noninferiority study in paediatric patients with an infection-induced fever, intravenous paracetamol 15 mg/kg treatment was shown to be no less effective than propacetamol 30 mg/kg in terms of antipyretic efficacy.
▴ Intravenous paracetamol was well tolerated in clinical trials, having a tolerability profile similar to placebo. Additionally, adverse reactions emerging from the use of the intravenous formulation of paracetamol are extremely rare (<1/10000).
KeywordsParacetamol Dipyrone Parecoxib Verbal Rating Scale Intravenous Paracetamol
The manuscript was reviewed by: B. Bannwarth, Department of Rheumatology, Victor Segalen University, Bordeaux, France; G.G. Graham, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
The preparation of this review was not supported by any external funding. During the peer review process, the manufacturer of the agent under review was offered an opportunity to comment on this article. Changes resulting from comments received were made on the basis of scientific and editorial merit.
- 10.Electronic Medicines Compendium. Ketorolac 30mg/ml solution for injection (Beacon pharmaceuticals): summary of product characteristics [online]. Available from URL: http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=20922 [Accessed 2008 Dec 12]
- 17.Electronic Medicines Compendium. Perfalgan 10mg/ml solution for infusion: summary of product characteristics [online]. Available from URL: http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=14288 [Accessed 2008 Aug 19]
- 21.Viscusi E, Royal M, Leclerc A, et al. Pharmacokinetics, efficacy and safety of IV acetaminophen in the treatment of pain following total hip arthroplasty: results of a double-blind, randomized, placebo-controlled, single-dose study [abstract no. 215 plus poster]. 24th Annual Meeting of the American Academy of Pain Medicine; 2008 Feb 12–16; Orlando (FL)Google Scholar
- 24.Schutz RA, Fong L, Chang Y, et al. Open-label, 4-period, randomized crossover study to determine the comparative pharmacokinetics of oral and intravenous acetaminophen administration in healthy male volunteers [poster only]. 32nd Annual Regional Anesthesia Meeting; 2007 Apr 19–22; Vancouver (BC)Google Scholar
- 38.Candiotti K, Singla N, Wininger S, et al. A randomized, double-blind, placebo-controlled, multi-center, parallel-group, multiple-dose study of the efficacy and safety of intravenous acetaminophen over 48 hours for the treatment of postoperative pain after gynecologic surgery [abstract no. A-13 plus poster]. 33rd Annual Regional Anesthesia Meeting; 2008 May 1–4; CancunGoogle Scholar
- 43.Gimbel J, Royal M, Leclerc A, et al. Efficacy and safety of IV acetaminophen in the treatment of pain following primary total hip arthroplasty: results of a double-blind, randomized, placebo-controlled, multiple-dose, 24 hour study [poster only]. 24th Annual Meeting of the American Academy of Pain Medicine; 2008 Feb 12–16; Orlando (FL)Google Scholar
- 44.Minkowitz H, Royal M, Leclerc A, et al. Efficacy and safety of IV acetaminophen in the treatment of pain following vaginal hysterectomy: results of a double-blind, randomized, placebo-controlled, multiple-dose, 24hour study [poster only]. 24th Annual Meeting of the American Academy of Pain Medicine; 2008 Feb 12–16; Orlando (FL)Google Scholar
- 45.Marty J, Benhamou D, Chassard D, et al. Effects of single-dose injectable paracetamol versus propacetamol in pain management after minor gynecologic surgery: a multicenter, randomized, double-blind, active-controlled, two-parallel-group study. Curr Ther Res Clin Exp 2005 Jul; 66(4): 294–306CrossRefGoogle Scholar
- 48.Khan ZU, Iqbal J, Saleh H, et al. Intravenous paracetamol is as effective as morphine in knee arthroscopic day surgery procedures. Pakistan J Med Sciences 2007; 23(6): 851–3Google Scholar
- 53.Alhashemi JA, Daghistani MF. Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children. Br J Anaesth 2006 Jun; 96(6): 790–5Google Scholar
- 54.Alhashemi JA, Daghistani MF. Effect of intraoperative intravenous acetaminophen vs. intramuscular meperidine on pain and discharge time after paediatric dental restoration. Eur J Anaesthesiol 2007 Feb; 24(2): 128–33Google Scholar
- 57.Singla N, Viscusi E, Candiotti K, et al. A review of the intravenous acetaminophen placebo-controlled clinical trial safety experience: a focus on hepatic transsaminases [poster only]. 33rd Annual Regional Anesthesia Meeting; 2008 May 1–4; CancunGoogle Scholar
- 58.Cadence Pharmaceuticals Inc. Cadence pharmaceuticals announces FDA concurrence with clinical development plan for acetavance™ [online]. Available from URL: http://cadx.client.shareholder.com/releases.cfm [Accessed 2008 Sep 1]
- 59.Electronic medicines compendium. Perfalgan 10mg/ml solution for infusion, 50 ml vial: patient information leaflet [online]. Available from URL: http://xpil.medicines.org.uk/ViewPil.aspx?DocID=19321 [Accessed 2008 Aug 19]